KC Lee, CMM Lui, TY Ng, SH Lo, KK Yuen, FCS Wong, WK Sze, TW Leung, SY Tung, SK O
Hong Kong J Radiol 2004;7:14-23
Objective: This report is of the experience with combination cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment for breast cancer at Tuen Mun Hospital.
Patients and Methods: Records of patients who received combination cyclophosphamide, methotrexate, and fluorouracil chemotherapy during 1990 to 2000